Jacqueline E. Shea - 25 Mar 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Operating Officer
Signature: /s/ Jacqueline E. Shea
Issuer symbol: INO
Transactions as of: 25 Mar 2022
Net transactions value: -$26,307
Form type: 4
Filing time: 28 Mar 2022, 16:05:46 UTC
Previous filing: 14 Mar 2022
Next filing: 11 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+16,666	+25%		83,802	25 Mar 2022	Direct	F1
transaction	INO	Common Stock	Tax liability	$26,307	-7,247	-8.6%	$3.63^*	76,555	25 Mar 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-16,666	-100%	$0.000000^*	0	25 Mar 2022	Common Stock	16,666		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares vested on March 25, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.